September 1, 2010, Mats Warstedt takes on the position as CEO of Innovativ Vision AB in Sweden, the world´s leading supplier of the WoodEye scanning equipment for the wood processing industry.

Priveq Investment is becoming a partner of Mediplast AB, a leader in consumables for healthcare. In 2009, Mediplast had sales of approximately SEK 310 m and has traced high growth through recent years. In tandem with Priveq’s investment, capital is also being injected into Mediplast to further accelerate its rate of expansion. The company’s current principal owner, Procurator AB, is remaining as a long-term owner.

-“In the midst of a tough exit market, we achieved our best exit ever and contributed to the creation of a new Swedish specialist pharmaceutical company with great international potential,” said Louise Nilsson, Partner and Investment Manager of Priveq Investment.

Priveq investment has as of today closed the exit transaction made on November 5th, 2009, thus sealing the outcome of the most successful exit, money multiple-wise, of our 27 years of history. The transaction was conditioned by a positive outcome in the Biovitrum EGM as of December 4th 2009.

Thereby concluding a >26x-investment, excluding a possible additional 3x dependant on further company performance, with an IRR exceeding 80 per cent we are happy to contribute to the initiation of a new, strong, Swedish specialist pharmaceutical company in the listed Swedish Orphan Biovitrum AB.

For more information, please contact us at +46 8 459 67 60.